Molecular pathology and genetics of gastrointestinal neuroendocrine tumours

@article{Lewis2014MolecularPA,
  title={Molecular pathology and genetics of gastrointestinal neuroendocrine tumours},
  author={M. Lewis and James Yao},
  journal={Current Opinion in Endocrinology & Diabetes and Obesity},
  year={2014},
  volume={21},
  pages={22–27}
}
  • M. Lewis, James Yao
  • Published 2014
  • Biology, Medicine
  • Current Opinion in Endocrinology & Diabetes and Obesity
Purpose of reviewNeuroendocrine tumours (NETs) of the luminal gastrointestinal tract and pancreas are increasing in incidence and prevalence. Prior assumptions about the benign nature of ‘carcinoids’ and the clinical importance of distinguishing functional vs. nonfunctional tumours are being overturned through greater understanding of disease behaviour and heterogeneity. This review highlights the most contemporary genetic and molecular insights into gastroenteropancreatic NETs. Recent… Expand
28 Citations
Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
Neuroendocrine Neoplasms of the Stomach
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Consensus on biomarkers for neuroendocrine tumour disease.
...
1
2
3
...

References

SHOWING 1-10 OF 44 REFERENCES
Neuroendocrine tumor disease: an evolving landscape.
The genomic landscape of small intestine neuroendocrine tumors.
Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors
Pathology - grading and staging of GEP-NETs.
Chromosome 3p alterations in pancreatic endocrine neoplasia
...
1
2
3
4
5
...